Clinical course of severe patients with COVID-19 treated with tocilizumab: report from a cohort study in Spain.
Chamorro-de-Vega E, Rodriguez-Gonzalez CG, Manrique-Rodríguez S, Lobato-Matilla E, García-Moreno F, Olmedo M, Correa-Rocha R, Valerio M, Aldámiz-Echevarria T, Machado M, Sancho-Gonzalez M, Lopez-Bernaldo-de-Quirós JC, Ruiz-Briones P, Romero-Jiménez R, Sarobe-González C, Gimenez-Manzorro A, Collado-Borrell R, Fernandez-Llamazares CM, Revuelta-Herrero JL, Somoza-Fernandez B, Garcia-Sanchez S, Taladriz-Sender I, Bouza E, Herranz A, Muñoz P, Sanjurjo M.
Chamorro-de-Vega E, et al.
Expert Rev Clin Pharmacol. 2021 Feb;14(2):249-260. doi: 10.1080/17512433.2021.1875819. Epub 2021 Jan 26.
Expert Rev Clin Pharmacol. 2021.
PMID: 33499687
Free PMC article.